Diagnostic Testing

CIKA is committed to providing funding for research into solid tumors


Diagnostic Testing - Cancer in Kids @ RCH - CIKA

The Diagnostic Testing programme was carried out in the Molecular Oncology Laboratory at the RCH. Its purpose was to develop of diagnostic testing, using molecular genetics, that will be applied to facilitate the diagnosis and monitoring of childhood solid tumours.

Expected Outcomes:
Establishment of accredited tests to enable tailored treatment protocols which should help reduce later life side effects from cancer treatment.

CIKA Funding Commencement:
2004

Expected Completion:
June 2005

Milestones:
NATA accreditation completed Nov 2004.
Automation of PCR based assays for molecular tests during 2005.

Cancers targetted:
Hepatoblastoma, desmoplastic small round cell tumour, rhabdomyosarcoma, neuroblastoma, Wilms' tumour, brain tumours, Ewing's sarcoma, and cancer related syndromes.

Achievements to date:
13 tests for solid tumours and tumour syndromes have been established and accredited.


Further details of this project were reported in the CIKA Newsletter for Summer 2004 which congratulated the lab team on achieving full NATA accreditation. This report can be found by clicking here.